No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
---|---|
Phenotype data |
473681 |
1. Apply sex-specific ruleNone |
473681 |
2. Check conditionsNone |
473681 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
522 |
4. Check minimum number of eventsNone |
522 |
5. Include endpointsNone |
522 |
6. Filter based on genotype QC (FinnGen only) |
494 |
Control definitions (FinnGen only)
Extra metadata
Similar endpoints
↥List of similar endpoints to Other and unspecified haemorrhagic conditions based on the number of shared cases.
Similar with more cases:
- Purpura and other haemorrhagic conditions
- Coagulation defects, purpura and other haemorrhagic conditions
- Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism
- Any event in hilmo or specialist outpatient
- Any prescribed medicine buy
Similar with less cases:
None
Case counts by codes
↥Summary Statistics
↥-FinRegistry-
Key figures
All | Female | Male | |
---|---|---|---|
Number of individuals | |||
Whole population | 4553 | 2524 | 1979 |
Only index persons | 3723 | 2126 | 1597 |
Unadjusted period prevalence (%) | |||
Whole population | 0.06 | 0.07 | 0.06 |
Only index persons | 0.07 | 0.08 | 0.06 |
Median age at first event (years) | |||
Whole population | 55.34 | 53.94 | 56.82 |
Only index persons | 52.24 | 50.26 | 54.86 |
-FinnGen-
Key figures
All | Female | Male | |
---|---|---|---|
Number of individuals | 494 | 296 | 198 |
Unadjusted period prevalence (%) | 0.11 | 0.12 | 0.10 |
Median age at first event (years) | 53.35 | 48.23 | 61.02 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
Mortality – FinRegistry
↥Association
Association between endpoint D3_HAEMORRHAGICNAS and mortality.
Females
Parameter | HR [95% CI] | p-value |
---|---|---|
D3_HAEMORRHAGICNAS | 2.577 [2.13, 3.11] | < 0.001 |
Birth year | 0.996 [0.99, 1.0] | 0.377 |
During the follow-up period (1.1.1998 — 31.12.2019), 542 out of 1833 females with D3_HAEMORRHAGICNAS died.
Males
Parameter | HR [95% CI] | p-value |
---|---|---|
D3_HAEMORRHAGICNAS | 2.773 [2.18, 3.53] | < 0.001 |
Birth year | 0.986 [0.98, 1.0] | 0.004 |
During the follow-up period (1.1.1998 — 31.12.2019), 549 out of 1402 males with D3_HAEMORRHAGICNAS died.
Mortality risk
Mortality risk for people of age
years, who have D3_HAEMORRHAGICNAS.N-year risk | Females | Males |
---|---|---|
1 | 0.304% | 0.488% |
5 | 1.55% | 3.02% |
10 | 3.838% | 7.322% |
15 | 6.969% | 14.394% |
20 | 12.299% | 23.449% |
Relationships between endpoints
↥Index endpoint: D3_HAEMORRHAGICNAS – Other and unspecified haemorrhagic conditions
GWS hits: -